About
Technology
Issues
FAQ
Links
Official Page
Tralokinumab plus topical corticosteroids for the treatment of moderate‐to‐severe atopic dermatitis: results from the double‐blind, randomized, multicentre, placebo‐controlled phase III ECZTRA 3 trial*
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.